<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336809">
  <stage>Registered</stage>
  <submitdate>13/04/2011</submitdate>
  <approvaldate>27/04/2011</approvaldate>
  <actrnumber>ACTRN12611000430932</actrnumber>
  <trial_identification>
    <studytitle>Does Morosil (red orange) extract reduce the risk factors of metabolic syndrome?</studytitle>
    <scientifictitle>The effect of Morosil extract in combination with nutritional intervention on the risk factors of metabolic syndrome</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Prevention of metabolic syndrome</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Other diet and nutrition disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Metabolic disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Morosil extract capsule 250mg oral administration, twice per day before meals for three months. Bioactive substances  present in this red orange juice extract include: Anthocyanins 0.8  0.9%, Flavonoids 2  2.2%, Hydroxycinnamic acid 0.8  1.0%, and Ascorbic acid 4.3  4.5%. 
Nutritional intervention involving the dietary recommendation on the individual bases will be provided to both groups. Participants will receive the recommendations once a week in the teaching clinic of Victoria University, St Albans campus.</interventions>
    <comparator>Placebo capsule containing maltodextrin, 250mg oral administration, twice per day before meals for three months.</comparator>
    <control>Placebo</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>weight loss - this will be assessed through physical measurement of body weight.</outcome>
      <timepoint>pre- and post-intervention</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>triglyceride reduction - blood analysis will be conducted.</outcome>
      <timepoint>pre- and post-intervention</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>reduction in waist circumference - this will be assessed through physical measurement.</outcome>
      <timepoint>pre- and post-intervention</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>change in basal metobolic rate (BMR) - this will be assessed using metabolic cart.</outcome>
      <timepoint>pre- and post-intervention</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>change in body composition examination using DEXA.</outcome>
      <timepoint>pre- and post-intervention</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Males and females aged 30-60 years with a BMI greater than 25 or a waist circumference &gt; 94cm for males and &gt;80cm for females.</inclusivecriteria>
    <inclusiveminage>30</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>60</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Liver, kidney and heart disease, pregnancy, type 1 and type 2 diabetes with insulin medication, cigarette smoking and the use of any medication for weight loss.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>numbered containers</concealment>
    <sequence>computer generated</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/05/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>50</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Victoria University</primarysponsorname>
    <primarysponsoraddress>McKechnie Street St Albans, PO BOX 14428 Melbourne, Victoria 8001</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Victoria University</fundingname>
      <fundingaddress>McKechnie Street St Albans, PO BOX 14428 Melbourne, Victoria 8001</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Commercial sector/Industry</sponsortype>
      <sponsorname>AZPA</sponsorname>
      <sponsoraddress>48 Translink Drive, Keilor Park VIC 3042</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>A 3-month intervention using encapsulated red orange (Citrus sinensis) juice extract in combination with nutritional intervention to investigate whether or not red orange juice extract decreases the risk factors of metabolic syndrome</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Victoira University Human Research Ethics Committee</ethicname>
      <ethicaddress>Office for Research, 
Victoria University,
PO Box 14428, 
Melbourne, VIC 8001</ethicaddress>
      <ethicapprovaldate>24/03/2011</ethicapprovaldate>
      <hrec>HRETH 11/43</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Michael Mathai; Xiao Su</name>
      <address>School of Biomedical &amp; Health Sciences
Victoria University
McKechnie Street
St Albans
PO Box 14428,
Melbourne VIC 8001</address>
      <phone>+61 3 9919 2211; +61 3 9919 2318</phone>
      <fax>+61 3 9919 2465</fax>
      <email>Michael.Mathai@vu.edu.au; xiao.su@vu.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Sue Mansour</name>
      <address>School of Biomedical &amp; Health Sciences
Victoria University
McKechnie Street
St Albans
PO Box 14428,
Melbourne VIC 8001</address>
      <phone>+61 3 9919 2318</phone>
      <fax>+61 3 9919 2465</fax>
      <email>sue_mansour@yahoo.com.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Xiao Su</name>
      <address>School of Biomedical &amp; Health Sciences
Victoria University
McKechnie Street
St Albans
PO Box 14428,
Melbourne VIC 8001</address>
      <phone>+61 3 9919 2318</phone>
      <fax>+61 3 9919 2465</fax>
      <email>xiao.su@vu.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>